Speakers

Dr. Birgit Schoeberl currently serves as the Global Head of Data42 at Novartis BioMedical Research (BR), based in Cambridge, USA. Data 42's mission is to provide Biomedical Research and Novartis with human- and AI-ready data and insights  across drug development stages. Under Birgit's leadership Data42 brings together innovative data science, enterprise data platforms, agentic solutions, and data governance under a single, integrated umbrella to unlock the full value of our data. 

Throughout her career in biotech and pharma, Birgit has been recognized for her innovative contributions in drug discovery and development, particularly through the use of data science,  AI/ML and quantitative systems pharmacology. 

Prior to her current role, she led Modeling and Simulation in PK Sciences at Novartis, where she built a novel and externally recognized Data Science and Modeling & Simulation function. Earlier in her career, she served as SVP of Science Delivery at GNS Healthcare and was a founding member a—and ultimately Chief Scientific Officer—at Merrimack Pharmaceuticals, where she pioneered systems biology approaches to drug development. Dr. Schoeberl earned her Ph.D. in Biological Engineering from the Max Planck Institute in Magdeburg, Germany, and completed a postdoctoral fellowship at MIT, where she developed early computational models of signaling networks.